Avalyn Pharma Inc. (AVLN)
NASDAQ: AVLNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
AVLN stock chart
Technical analysisKey statistics
All statistics- Market cap
- $1.13B
- EPS (TTM)
- -$2.47
- Dividend yield
- None
- 52-week range
- 24.15 – 40.17
- Day range
- 25.26 – 26.31
- Volume / Avg
- 202.93K / 238.20K
- Beta
- —
- Shares outstanding
- 44.33M
52-week range
AVLN stock today
Avalyn Pharma (AVLN) closed at $25.53 on Oct 7, up 0.39% (+$0.10), versus the S&P 500's 0.22% decline. Shares are 36.4% below their 52-week high of $40.17, set on Aug 18, 2026 and 5.7% above the 52-week low of $24.15, near the bottom of the past year's range. Avalyn Pharma has posted a net loss over the last twelve months (EPS of -$2.47), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Avalyn Pharma
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2026
Avalyn Pharma peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| MNKDMannKind Corporation | 3.45 | -7.01% | $1.11B | vs AVLN |
| HROWHarrow Inc. | 30.62 | +0.89% | $1.15B | vs AVLN |
| LBRXLB Pharmaceuticals Inc | 34.16 | -0.29% | $1.10B | vs AVLN |
| JANXJanux Therapeutics Inc. | 17.92 | +6.73% | $1.10B | vs AVLN |
| TRAXFirst Tracks Biotherapeutics Inc. | 30.59 | -2.55% | $1.09B | vs AVLN |
| BCAXBicara Therapeutics Inc. | 16.42 | -0.85% | $1.09B | vs AVLN |
| AMPHAmphastar Pharmaceuticals Inc. | 25.54 | -1.43% | $1.09B | vs AVLN |
| OPKOPKO Health Inc. | 1.39 | -4.79% | $1.04B | vs AVLN |
Indexes, lists and sector
Avalyn Pharma stock FAQ
What is Avalyn Pharma's stock price today?
AVLN last traded at $25.53 as of Oct 7, 4:00 PM EDT, up 0.39% on the day. Prices are delayed at least 15 minutes.
What is the AVLN 52-week high?
The 52-week high for AVLN is $40.17 and the 52-week low is $24.15. The stock is currently 36.4% below its high.